XML 48 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023
9 Months Ended
Sep. 30, 2024
Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023  
Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023

21.

Effect of the revision on the Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2023

In connection with the preparation of our consolidated financial statements for the year ended December 31, 2023, we identified an adjustment related to the accounting treatment of foreign exchange on goods in transit in Nigeria in the quarterly periods ended June 30, 2023, and September 30, 2023. The adjustment reclassified these foreign exchange movements from Inventories and Property, plant and equipment to Cost of sales and Finance costs. In accordance with SAB No. 99, “Materiality,” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”, we evaluated the adjustment and determined that the related impact was not material to our financial statements for any prior period. Accordingly, we have revised previously reported financial information, disclosed in our Quarterly Report on Form 6-K for the periods ended June 30, 2023, and September 30, 2023. The following table summarizes the impact of the revision in the current period.

CONDENSED CONSOLIDATED STATEMENT OF LOSS AND OTHER COMPREHENSIVE INCOME (UNAUDITED)

Three months ended September 30, 2023

Nine months ended September 30, 2023

As previously reported

Adjustments

Revised

As previously reported

Adjustments

Revised

  

$’000

  

$’000

  

$’000

    

$’000

  

$’000

  

$’000

Cost of sales

(365,032)

6,149

(358,883)

(949,774)

(12,854)

(962,628)

Operating income

7,478

6,149

13,627

369,248

(12,854)

356,394

Finance costs

(261,993)

(9,602)

(271,595)

(1,804,222)

(12,642)

(1,816,864)

Loss before income tax

(248,692)

(3,453)

(252,145)

(1,416,741)

(25,496)

(1,442,237)

Loss for the period

(265,351)

(3,453)

(268,804)

(1,505,859)

(25,496)

(1,531,355)

Loss attributable to:

  

  

Owners of the Company

(263,377)

(3,453)

(266,830)

(1,497,525)

(25,496)

(1,523,021)

Loss for the period

(265,351)

(3,453)

(268,804)

(1,505,859)

(25,496)

(1,531,355)

Loss per share - basic

(0.79)

(0.01)

(0.80)

(4.49)

(0.08)

(4.57)

Loss per share - diluted

(0.79)

(0.01)

(0.80)

(4.49)

(0.08)

(4.57)

Other comprehensive income:

  

  

Exchange differences on translation of foreign operations

4,789

557

5,346

629,755

5,047

634,802

Other comprehensive income for the period, net of taxes

4,789

557

5,346

629,755

5,047

634,802

Total comprehensive loss for the period

(260,562)

(2,896)

(263,458)

(876,104)

(20,449)

(896,553)

Total comprehensive loss attributable to:

  

  

Owners of the Company

(251,373)

(2,896)

(254,269)

(876,163)

(20,449)

(896,612)

Total comprehensive loss for the period

(260,562)

(2,896)

(263,458)

(876,104)

(20,449)

(896,553)

NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (CONTINUED)

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (UNAUDITED)

 

As previously reported

 

Adjustments

 

Revised

Accumulated

Other

Accumulated

Other

Accumulated

Other

losses

reserves

losses

reserves

losses

reserves

    

$’000

  

$’000

    

$’000

  

$’000

    

$’000

  

$’000

Balance at January 1, 2023

 

(3,317,652)

(861,271)

(3,317,652)

(861,271)

Loss for the period

 

(1,497,525)

(25,496)

(1,523,021)

Other comprehensive income

 

621,362

5,047

626,409

Total comprehensive (loss)/income

 

(1,497,525)

621,362

(25,496)

5,047

(1,523,021)

626,409

Balance at September 30, 2023

 

(4,814,310)

(321,440)

(25,496)

5,047

(4,839,806)

(316,393)

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)

Three months ended September 30, 2023

Nine months ended September 30, 2023

As previously reported

Adjustments

Revised

As previously reported

Adjustments

Revised

  

$’000

  

$’000

  

$’000

    

$’000

  

$’000

  

$’000

Cash flows from operating activities

  

  

  

  

  

  

Cash from operations

234,437

(4,524)

229,913

750,428

(9,559)

740,869

Net cash generated from/(used in) operating activities

224,777

(4,524)

220,253

703,547

(9,559)

693,988

Cash flow from investing activities

  

  

  

  

  

  

Purchase of property, plant and equipment

(124,413)

4,524

(119,889)

(393,015)

9,559

(383,456)

Net cash (used in)/generated from investing activities

(188,129)

4,524

(183,605)

(638,282)

9,559

(628,723)

Net cash used in financing activities

(29,115)

(29,115)

(11,806)

(11,806)

Cash and cash equivalents at end of period

425,436

425,436

425,436

425,436

Commensurate adjustments have been made to notes 5, 6, 9, 11 and 18 to the financial statements.